Brief: Collegium Pharmaceutical Q3 Revenue USD 136.7 Million Vs. IBES Estimate USD 138.3 Million
07/11/2023 21:01
Nov 07 (Reuters) - Collegium Pharmaceutical Q3 adjusted EBITDA USD 89.4 million. * Q3 net income USD 20.6 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%